Navigation Links
Express Scripts Reports Fourth Quarter Results
Date:2/22/2012

rder to compare the underlying financial performance to prior periods. Appendix Footnotes (1) These claims include home delivery, specialty and other claims including:  (a) drugs distributed through patient assistance programs (b) drugs we distribute to other PBM's clients under limited distribution contracts with pharmaceutical manufacturers and (c) FreedomFP claims. (2) Total adjusted claims reflect home delivery claims multiplied by 3, as home delivery claims typically cover a time period 3 times longer than retail claims. (3) Amortization of NextRx-related intangible assets include amounts in both revenues and selling, general and administrative expense. Revenue amortization is related to the customer contract with WellPoint which consummated upon closing of the NextRx acquisition in 2009.  Under U.S. GAAP standards, amortization of intangibles that arise in connection with consideration given to a customer by a vendor is characterized as a reduction of revenues.  Intangible amortization of $28.5 million ($17.9 million and $18.1 million net of tax, respectively) is included as a reduction to revenue for the three months ended December 31, 2011 and 2010 and $114.0 million ($71.9 million net of tax) is included as a reduction to revenue for the years ended December 31, 2011 and 2010.  
In addition, intangible amortization of $1.7 million ($1.1 million net of tax) is included in selling, general and administrative expense in the three months ended December 31, 2011 and 2010 and $6.5 million ($4.1 million net of tax) is included in selling, general and administrative expense in the years ended December 31, 2011 and 2010. (4) Integration-related costs include those costs directly related to the acquisition of NextRx, primarily comprised of transition services, integration, site closures and severance costs.  $31.8 million ($20.2 million net of tax) is included in cost of revenues for the three months ended December 31, 2010 and $94.5 mil
'/>"/>
SOURCE Express Scripts, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. ALS TDI Completes Gene Expression Profile of Lou Gehrigs Disease in Mice
2. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
3. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
4. TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
5. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
6. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
7. Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients
8. International Medical Corps Matched with Top 25 American Express Members Project, Saving the Lives of Malnourished Children
9. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
10. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014   Royal Philips (NYSE: ... it has received 510(k) clearance from the U.S. ... planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. ... interventionalists with pre-procedural, high-precision positioning to treat aortic ... application is available as part of Philips ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... a healthcare investment firm with offices in Palo Alto, ... of Vivo Ventures VII ("Vivo VII") at $375 million, ... more than $1 billion. Vivo plans ... pharmaceutical and medical device companies in the U.S. and ...
... Therapeutics, Inc. (NASDAQ: ECTE ), a ... a non-invasive, wireless, transdermal continuous glucose monitoring system ... delivery, today announced that Patrick T. Mooney, M.D., ... at the Biotech Showcase 2012 Conference. ...
Cached Medicine Technology:Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China 2Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco 2
(Date:8/22/2014)... For the fourth time, TharpeRobbins, a global leader ... received a prestigious level of recognition from Inc. Magazine. ... remains on the exclusive list of top 5000 fastest ... the list in 2010, 2011 and 2013. , ... list for a fourth time," says Brett Tharpe, CEO ...
(Date:8/22/2014)... Omaha, NE (PRWEB) August 22, 2014 ... has once again earned a position on the Inc. ... healthcare staffing company placed in position 1424 on the ... revenue of $126.2 million. This marks the seventh time ... earned a spot on the Inc. 5000, including one ...
(Date:8/22/2014)... Kicking blog MichaelHusted.com is featuring an interview ... his role as a kicking coach, his kicking business, and ... retired NFL kicker Michael Husted author of Husted Kicking.com. , ... him join our NCS Network,” says Husted. β€œHe brings a ... will continue to strengthen our coaching staff and the NCS ...
(Date:8/22/2014)... 2014 An increasing number of mergers ... in the market. M&As provide financial assistance to smaller ... rise the distribution channels of companies and help in ... markets. , According to the β€œ Global Animal Health ... and protein-rich diet is one of the major drivers ...
(Date:8/22/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on Diamondback 360 Peripheral ... announced on August 19, that certain lots of the ... (Part number 7-10003), by Cardiovascular Systems, are recalled ... could fracture during use and could possibly block blood ...
Breaking Medicine News(10 mins):Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 3Health News:Medical Solutions Earns Position on the 2014 Inc. 5000 List 2Health News:MichaelHusted.com Interviews Coach Brian Jackson of Team Jackson Kicking on His Role as a Kicking Coach, and on Becoming a National Camp Series (NCS) Associate 2Health News:MichaelHusted.com Interviews Coach Brian Jackson of Team Jackson Kicking on His Role as a Kicking Coach, and on Becoming a National Camp Series (NCS) Associate 3Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 2Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 3Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 4Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2
... in an extremely exciting phase right now. We are ... formed and are starting clinical trials in different areas," ... first-in-human study was just initiated for Parkinson,s disease patients ... NeuroNova. The drug, which is administered into the fluid-filled ...
... ST. PAUL, Minn., May 21 Three HealthEast ... agreed to pay the federal government a total ... tam") lawsuit alleging Medicare fraud involving a certain ... hospitals are the first hospitals to settle charges ...
... FRANCISCO -- Mayo Clinic researchers have found that bipolar ... as diabetes, depression, asthma or coronary artery disease. These ... claim costs. Specialty care costs (the costs of seeing ... for bipolar patients. Results of this review are being ...
... May 21 Elimination of funding for ... by the Senate Republican budget plan would end a ... rate of health care cost increases, improving quality of ... today.For the past two years the small "think tank" ...
... HMS today announced that it had been awarded contracts ... million lives to the company,s portfolio. HMS will be providing ... party recovery and cost avoidance -- to Citrus Health Care, ... (NY); Health First (NY); Health Plan of Michigan, Inc. (MI); ...
... (May 21, 2009) In comparing ultrasound with other medical ... review of published studies in the May/June issue of ... of ultrasound to provide an accurate diagnosis more cost ... the 1950s, ultrasound has been utilized mostly in hospital settings. ...
Cached Medicine News:Health News:Minnesota Hospitals Pay $2.28 Million to Settle Medicare Fraud Charges Involving Kyphoplasty 2Health News:Minnesota Hospitals Pay $2.28 Million to Settle Medicare Fraud Charges Involving Kyphoplasty 3Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 2Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 3Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 4
... The unique triple-mode technology ... all-around system for an array ... technology includes a patented, controllable ... mode for classical ablation procedures, ...
... Test is the only in-office test approved by ... The NMP22 BladderChek Test is a painless and ... that detects elevated levels of NMP22 protein. Healthy ... protein in the urine. However, the level of ...
ARION is a long-pulsed alexandrite laser system with a wavelength of 755 nm...
Used for measuring rectal pressure during urodynamic studies. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open pack...
Medicine Products: